Full-Time

VP – Clinical Operations Excellence

Posted on 1/17/2025

Relay Therapeutics

Relay Therapeutics

201-500 employees

Biotech company focused on drug discovery

Biotechnology
Healthcare

Expert

Cambridge, MA, USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • 10+ years of experience in the biopharma or CRO industry with a thorough understanding of clinical study processes
  • Strong and current knowledge in Good Clinical Practices and ICH Guidelines and the application to the conduct of clinical studies
  • Successful experience from at least one fast-paced entrepreneurial biotech company
  • Proactive problem solver who identifies solutions to problems before they arise
  • Recognized as a clinical operations expert with a track record of success and innovative program execution
  • Strategic planning, attention to detail, and an analytical approach to problem solving
  • Ability to mentor and develop talent in the organization
Responsibilities
  • Build, deploy and maintain all elements of a Risk-Based Quality Management (RBQM) approach in accordance with ICH E6R2 requirements for all clinical trials
  • Define the 'Relay Way' of executing clinical studies and implement a CRO-partnership model
  • Define standard expectations and ways of working (i.e. Operations Manual)
  • Lead the vendor Joint Oversight Committees (JOCs) in partnership with ClinOps Leads and CBO
  • Define, implement and report measurable functional parameters framework metrics (OKMs/KPI/KRIs) for internal and external stakeholders
  • Lead the Vendor Governance efforts
  • Partner with CBO and QA to ensure clear process for vendor qualification and maintenance
  • Participate in preparation for vendor audits, review reports, ensure resolution of findings
  • Oversee eTMF team for all Relay TX Trials
  • Ensure Relay review and oversight of Quality Events (QE) resolution with the vendor
  • Evaluate needs for CDO team training and either source training or develop in-house
  • Lead lessons learned initiatives
  • Oversee training compliance across Precision Medicines
  • Drive the creation, evaluation and delivery of tools, templates, new systems, technologies, and guidance for best practice
  • Oversee new SOP (WI, Form, Template) creation for CDO-owned SOPs
  • Oversee the periodic review of CDO-owned QDs and cross-functional SOPs

Relay Therapeutics focuses on drug discovery by emphasizing the movement of proteins in its research. The company uses its Dynamo™ platform, which integrates experimental and computational methods, to identify and develop new drugs, particularly for complex diseases that are hard to treat with current therapies. This platform enables Relay to target proteins that have previously been difficult to address, expanding treatment options in areas like precision oncology and genetic diseases. Unlike many competitors, Relay's approach is centered on understanding protein dynamics, which sets it apart in the biotech field. The goal of Relay Therapeutics is to create impactful medicines for patients, and it is engaged in clinical trials to ensure the safety and effectiveness of its drug candidates.

Company Stage

IPO

Total Funding

$535M

Headquarters

Cambridge, Massachusetts

Founded

2016

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

2%
Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven drug discovery complements Relay's computational techniques, enhancing drug development.
  • Quantum computing integration could boost Dynamo's capabilities in drug discovery.
  • Rising personalized medicine trend aligns with Relay's precision medicine focus.

What critics are saying

  • Increased competition from VantAI threatens Relay's market position.
  • Layoffs may impact Relay's operational efficiency and research progress.
  • Reliance on public offerings suggests potential financial instability for Relay.

What makes Relay Therapeutics unique

  • Relay's Dynamo platform targets previously undruggable proteins, expanding treatment possibilities.
  • Focus on protein motion places Relay at the forefront of innovative drug discovery.
  • Relay's precision oncology approach tailors treatments to individual genetic profiles.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Medical, dental, vision

Life, disability, & FSA

401k

Commuter benefits

Parental leave

Home office stipend

Tuition reimbursement

PTO